BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Pilot Study to Assess Number of Patients for Main Trial
Phase 4
Completed
- Conditions
- Wound Healing
- Interventions
- First Posted Date
- 2016-04-12
- Last Posted Date
- 2016-04-12
- Lead Sponsor
- Bayer
- Target Recruit Count
- 28
- Registration Number
- NCT02734628
Treatment Patterns in Metastatic Prostate Cancer
- First Posted Date
- 2016-04-06
- Last Posted Date
- 2018-01-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 565
- Registration Number
- NCT02729103
Evaluation of the Irritation Potential of Products in Human Eyes.
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Other: Sunscreen Spray SPF50 Z15-034(BAY987516)Other: Shampoo ControlOther: Sunscreen Spray SPF50 Z15-038(BAY987516)
- First Posted Date
- 2016-04-05
- Last Posted Date
- 2017-03-31
- Lead Sponsor
- Bayer
- Target Recruit Count
- 48
- Registration Number
- NCT02728856
Exploratory Study for Allergy Relief Onset
Phase 2
Terminated
- Conditions
- Rhinitis, Allergic
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-03-29
- Last Posted Date
- 2018-12-12
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1
- Registration Number
- NCT02722083
18841- Sun Protection Factor Assay
Not Applicable
Completed
- Conditions
- Sunscreening Agent
- Interventions
- Drug: Coppertone (BAY 987517)
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 10
- Registration Number
- NCT02717351
18842 - Sun Protection Factor Assay
Not Applicable
Completed
- Conditions
- Sunscreening Agent
- Interventions
- Drug: Coppertone (BAY987517)
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 10
- Registration Number
- NCT02717325
Evaluation of the Irritation Potential of Products in Human Eyes
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Other: Ophthalmic OintmentOther: Sunscreen lotion SPF (Sun Protection Factor) 50 (BAY987521)
- First Posted Date
- 2016-03-21
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Bayer
- Target Recruit Count
- 24
- Registration Number
- NCT02714166
YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China
Phase 4
Completed
- Conditions
- Contraception
- Interventions
- Drug: EE20/DRSP (YAZ, BAY86-5300)
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2019-06-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1921
- Registration Number
- NCT02710708
Second Primary Cancers in Patients With Castration Resistant Prostate Cancer
Completed
- Conditions
- Prostatic Neoplasms
- First Posted Date
- 2016-03-09
- Last Posted Date
- 2018-01-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 6442
- Registration Number
- NCT02702908
Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment
Phase 1
Completed
- Conditions
- Neoplasms
- Interventions
- Drug: Anetumab ravtansine (BAY94-9343)
- First Posted Date
- 2016-03-02
- Last Posted Date
- 2021-07-09
- Lead Sponsor
- Bayer
- Target Recruit Count
- 54
- Registration Number
- NCT02696642
© Copyright 2025. All Rights Reserved by MedPath